Cargando…

Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis

BACKGROUND: High platelet reactivity (HPR) and low platelet reactivity (LPR) are associated with an increased risk of ischemic/bleeding events in patients undergoing percutaneous coronary intervention (PCI). The role platelet miRNAs carry out in platelet reactivity regulation is largely unknown. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinghan, Yao, Yi, Zhang, Jiahui, Tang, Xiaofang, Meng, Xianmin, Wang, Miao, Song, Lei, Yuan, Jinqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186638/ https://www.ncbi.nlm.nih.gov/pubmed/32355808 http://dx.doi.org/10.21037/atm.2020.02.88

Ejemplares similares

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
por: Wang, Jing, et al.
Publicado: (2021)

High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention
por: Zhang, Jun-Jie, et al.
Publicado: (2016)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
por: Jiang, Xiao-Min, et al.
Publicado: (2018)

Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
por: Zhang, Yang, et al.
Publicado: (2021)

Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Yao, Yi, et al.
Publicado: (2016)

Platelet Reactivity Was Not Associated with Infarct Size after Primary Percutaneous Coronary Intervention
por: Park, Seohwa, et al.
Publicado: (2021)

Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
por: Lianos, Ioannis, et al.
Publicado: (2022)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021)

Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention
por: Seyyed-Mohammadzad, Mir Hossein, et al.
Publicado: (2015)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
por: Mutschlechner, David, et al.
Publicado: (2023)

Interplay between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention
por: Siller-Matula, Jolanta M., et al.
Publicado: (2014)

Flavanols and Platelet Reactivity
por: Pearson, Debra A., et al.
Publicado: (2005)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
por: Aradi, Dániel, et al.
Publicado: (2014)

Mind the Gap: Platelet Inhibition in Low‐Risk Acute Coronary Syndrome Undergoing Percutaneous Revascularization
por: Sharma, Ravi K., et al.
Publicado: (2019)

BCL-2 is dispensable for thrombopoiesis and platelet survival
por: Debrincat, M A, et al.
Publicado: (2015)

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
por: Spartalis, Michael, et al.
Publicado: (2017)

Large-Scale Profiling on lncRNAs in Human Platelets: Correlation with Platelet Reactivity
por: Sun, Yeying, et al.
Publicado: (2022)

The Relationship between Fractional Flow Reserve, Platelet Reactivity and Platelet Leukocyte Complexes in Stable Coronary Artery Disease
por: Sels, Jan-Willem E. M., et al.
Publicado: (2013)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity
por: Schuurman, Alex R., et al.
Publicado: (2022)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Platelet reactivity expressed as a novel platelet reactivity score is associated with higher inflammatory state after coronary artery bypass grafting
por: Wilczyński, Mirosław, et al.
Publicado: (2019)

Comprehensive Characterization of Platelet-Enriched MicroRNAs as Biomarkers of Platelet Activation
por: Krammer, Teresa L., et al.
Publicado: (2022)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2014)

Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
por: Song, Kai, et al.
Publicado: (2022)

Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
por: van Bladel, Esther R, et al.
Publicado: (2012)

Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
por: Arvanitidis, Efthymios, et al.
Publicado: (2017)

Platelet olfactory receptor activation limits platelet reactivity and growth of aortic aneurysms
por: Morrell, Craig N., et al.
Publicado: (2022)

Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
por: Elstrott, Benjamin K., et al.
Publicado: (2022)

Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases
por: Josefsson, Emma C., et al.
Publicado: (2020)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
por: Han, Ya-Ling
Publicado: (2019)

Impact of platelet endothelial aggregation receptor 1 genotypes and DNA methylation on platelet reactivity in patients with recurrent ischemic stroke treated with clopidogrel
por: Yang, Jiahui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nq3qdcva09ahhdihredh461ng